Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Vicki Madden Women with epilepsy are not getting the advice they need on issues
relating to contraception and pregnancy, according to a survey of women
members of the British Epilepsy Association (Seizure 1999;8:135-9).
A total of 1855 women aged 16 or older with epilepsy returned
questionnaires sent to 6000 women members of the association. Half of
the women, aged between 16 and 55 claimed to have received no advice
about possible interactions between their antiepileptic drug treatments
and the methods of contraception they used.
Of the 189 women taking the oral contraceptive pill, only 43%had been
given advice about the reduced effectiveness of the pill when it was
taken together with enzyme inducing antiepileptic drugs, and
16%claimed to have received no information at all.
While nearly half (47%) of those surveyed had children and 23%were
planning to have children in the future, one third claimed to have
received no advice about the effects of epilepsy on their pregnancy.
The teratogenicity of anti-epileptic medication was discussed with only
15%of those women who planned to have children within the next two
years. Prepregnancy counselling and the need for folic acid
supplementation and extra monitoring during pregnancy was discussed
with only a tiny minority (5%) of the women.
Commenting on the findings of the survey, Dr Pamela Crawford,
consultant neurologist at York District Hospital, said that women with
epilepsy should aim to be taking the lowest possible dose of a single
drug that will control their seizures
Read all Rapid Responses
What can you learn from this BMJ paper? Read Leanne Tite's Paper+